You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 7,767,223


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,767,223
Title:Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
Abstract:Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s): Wong; Vernon G. (Menlo Park, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:11/180,079
Patent Claim Types:
see list of patent claims
Use; Compound; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

The U.S. patent system is a complex and vital component of innovation and intellectual property protection in the United States. To navigate this system effectively, it is crucial to understand the scope and claims of patents, as well as the broader patent landscape. This article will delve into the key aspects of U.S. patents, including the probability of receiving a patent, the role of the U.S. Patent and Trademark Office (USPTO), patent claims and scope, and recent developments in patent law.

The U.S. Patent and Trademark Office (USPTO)

The USPTO is the federal agency responsible for granting U.S. patents and registering trademarks. It plays a pivotal role in the patent application process, from receiving and examining applications to granting patents[2].

Probability of Receiving a U.S. Patent

Contrary to the common belief that the USPTO approves nearly all patent applications, the actual approval rate is significantly lower. A study analyzing 2.15 million U.S. patent applications from 1996 to mid-2013 found that only 55.8% of these applications were eventually granted as patents without using continuation procedures. The allowance rate has decreased over time, particularly in fields such as "Drugs and Medical Instruments" and "Computers and Communications"[1].

Patent Application Process

The patent application process involves several steps, including filing, examination, and potential continuation applications. The USPTO's internal databases, such as the Patent Application and Information Retrieval (PAIR) system, provide detailed records of the prosecution histories of patent applications. This data helps in understanding the outcomes of patent applications, including allowances, abandonments, and continuations[1].

Patent Claims and Scope

Patent claims define the scope of protection for an invention. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset includes claim-level statistics and document-level statistics, helping to measure patent scope and complexity[3].

Determining Patentability

The patentability of an invention is determined by whether the patent claims are directed to eligible subject matter. The Alice/Mayo test, established by the Supreme Court, requires that patent claims not be directed to laws of nature, natural phenomena, or abstract ideas unless they contain an "inventive concept" that transforms the nature of the ineligible concept[4].

Recent Developments in Patent Law

The Leahy-Smith America Invents Act (AIA)

The AIA, enacted in 2011, is one of the most significant changes to U.S. patent law in over 50 years. It introduced the Patent Trial and Appeal Board (PTAB) within the USPTO, which has the authority to hear administrative challenges to the validity of previously granted patents. This includes inter partes review, a process that allows third parties to challenge the validity of a patent after it has been granted[4].

Small Claims Patent Court

There has been ongoing discussion and study on the feasibility of a small claims patent court. The Administrative Conference of the United States (ACUS) conducted a study to explore the need, structure, and legal considerations for such a court. This initiative aims to provide a more accessible and cost-effective way for small entities to resolve patent disputes[5].

Technology Fields and Patent Trends

Patent applications are categorized into various technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous "Other" category. The allowance rates and trends vary significantly across these fields. For instance, the "Drugs and Medical Instruments" and "Computers and Communications" fields have seen a substantial decrease in allowance rates over time[1].

Impact of Continuation Applications

Continuation applications allow applicants to file additional applications related to their original application. These can significantly affect the overall allowance rate and the complexity of the patent prosecution process. Understanding the role of continuation applications is crucial for navigating the patent system effectively[1].

Economic and Legal Implications

The patent system has profound economic and legal implications. Patents can provide a competitive edge and protect intellectual property, but they can also be subject to challenges and disputes. The PTAB and inter partes review processes have changed the landscape of patent litigation, making it more accessible for third parties to challenge patent validity[4].

Stakeholder Perspectives

Various stakeholders, including inventors, small entities, and large corporations, have different perspectives on the patent system. Small entities often face significant challenges in navigating the complex and costly patent system, which is why initiatives like the small claims patent court are being explored[5].

Case Study: United States Patent 7,767,223

To illustrate the complexities of patent claims and scope, let's consider an example. United States Patent 7,767,223, while not specifically detailed here, would typically involve a thorough examination of its claims, the technology field it belongs to, and the prosecution history. This would include analyzing the patent's eligibility under the Alice/Mayo test and understanding any continuations or related applications.

Claims Analysis

A detailed analysis of the claims would involve identifying the independent and dependent claims, understanding the dependencies between them, and assessing the scope of protection they provide. This analysis is crucial for determining the patent's validity and potential infringement issues.

Prosecution History

Reviewing the prosecution history through the PAIR system would provide insights into the interactions between the applicant and the USPTO, including any office actions, responses, and amendments. This history can reveal challenges faced during the examination process and how they were addressed.

Key Takeaways

  • Approval Rate: Only about 55.8% of patent applications are granted without using continuation procedures.
  • Technology Fields: Allowance rates vary significantly across different technology fields.
  • Patent Claims: Claims define the scope of protection and must meet eligibility criteria.
  • Recent Developments: The AIA introduced significant changes, including the PTAB and inter partes review.
  • Small Claims Court: There is ongoing discussion about establishing a small claims patent court to aid small entities.

FAQs

What is the role of the USPTO in the patent application process?

The USPTO is responsible for receiving, examining, and granting U.S. patents. It also registers trademarks and provides various databases and tools for patent applicants.

What is the typical approval rate for U.S. patent applications?

Only about 55.8% of patent applications are granted without using continuation procedures, with the allowance rate decreasing over time in certain fields.

How are patent claims determined to be eligible for protection?

Patent claims must not be directed to ineligible subject matter such as laws of nature, natural phenomena, or abstract ideas unless they contain an "inventive concept" under the Alice/Mayo test.

What is the significance of the Leahy-Smith America Invents Act (AIA)?

The AIA introduced the PTAB and inter partes review, allowing third parties to challenge the validity of previously granted patents through administrative processes.

Why is there a discussion about a small claims patent court?

A small claims patent court is being considered to provide a more accessible and cost-effective way for small entities to resolve patent disputes.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. U.S. Patent and Trademark Office (USPTO). Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO Economic Working Paper 2016-04. Patent Claims and Patent Scope. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Congressional Research Service. (2024). The Patent Trial and Appeal Board and Inter Partes Review. Retrieved from https://crsreports.congress.gov/product/pdf/R/R48016
  5. Administrative Conference of the United States (ACUS). U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,767,223

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,767,223

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 306951 ⤷  Subscribe
Australia 2002236495 ⤷  Subscribe
Australia 2006201271 ⤷  Subscribe
Australia 3649502 ⤷  Subscribe
Brazil 0115772 ⤷  Subscribe
Canada 2429998 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.